NASDAQ:ITCI

Intra-Cellular Therapies Insider Trades

$57.88

+0.15 (+0.26%)

(As of 05/20/2022 12:00 AM ET)

Add

Compare

Today's Range: $55.55
▼
$59.85
50-Day Range: $43.00
▼
$65.64
52-Week Range: $28.40
▼
$66.00

Volume: 873,853 shs
Average Volume: 1.08 million shs
Market Capitalization: $5.46 billion

P/E Ratio: N/A
Dividend Yield: N/A
Beta: 1.28

Current Insider Ownership Percentage: 13.20%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 8
Amount Of Insider Selling (Last 12 Months): $42.40 M

Insider Buying and Selling by Quarter

Get ITCI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intra-Cellular Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Intra-Cellular Therapies (NASDAQ:ITCI) Insider Trading History

Export to Excel

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/12/2022	Joel S Marcus	Director	Sell	10,000	$55.00	$550,000.00	54,233
4/8/2022	Mark Neumann	EVP	Sell	86,348	$64.37	$5,558,220.76	45,339
3/18/2022	Rory B Riggs	Director	Sell	20,637	$61.18	$1,262,571.66
3/16/2022	Rory B Riggs	Director	Sell	64,534	$59.27	$3,824,930.18
3/7/2022	Joel S Marcus	Director	Sell	5,000	$54.52	$272,600.00
3/4/2022	Suresh K Durgam	Insider	Sell	3,860	$55.52	$214,307.20
3/2/2022	Suresh K Durgam	Insider	Sell	4,177	$56.98	$238,005.46
2/24/2022	Lawrence J Hineline	CFO	Sell	7,454	$51.97	$387,384.38
2/24/2022	Mark Neumann	EVP	Sell	7,906	$52.21	$412,772.26
2/24/2022	Sharon Mates	CEO	Sell	22,589	$51.98	$1,174,176.22

2/24/2022	Suresh K Durgam	Insider	Sell	4,046	$52.27	$211,484.42
2/22/2022	Lawrence J Hineline	CFO	Sell	10,443	$55.40	$578,542.20
2/22/2022	Mark Neumann	EVP	Sell	11,139	$55.29	$615,875.31
2/22/2022	Sharon Mates	CEO	Sell	27,847	$55.39	$1,542,445.33
2/22/2022	Suresh K Durgam	Insider	Sell	4,177	$55.29	$230,946.33
1/18/2022	Suresh K Durgam	Insider	Sell	6,223	$42.03	$261,552.69
1/10/2022	Lawrence J Hineline	CFO	Sell	19,639	$40.76	$800,485.64
1/10/2022	Mark Neumann	EVP	Sell	20,948	$40.78	$854,259.44
1/10/2022	Sharon Mates	CEO	Sell	41,896	$40.78	$1,708,518.88
1/10/2022	Suresh K Durgam	Insider	Sell	6,870	$40.76	$280,021.20
12/21/2021	Lawrence J Hineline	CFO	Sell	175,000	$47.59	$8,328,250.00
12/21/2021	Michael Halstead	EVP	Sell	176,863	$47.56	$8,411,604.28
10/18/2021	Mark Neumann	EVP	Sell	13,448	$40.86	$549,485.28
10/18/2021	Sharon Mates	CEO	Sell	8,192	$40.00	$327,680.00
10/15/2021	Sharon Mates	CEO	Sell	40,392	$40.00	$1,615,680.00
6/14/2021	Joel S Marcus	Director	Sell	18,289	$42.27	$773,076.03	13,767
5/27/2021	Christopher D Alafi	Director	Sell	8,482	$40.01	$339,364.82	346,795
5/24/2021	Christopher D Alafi	Director	Sell	26,575	$40.47	$1,075,490.25	346,795
5/21/2021	Christopher D. Alafi	Director	Sell	1,100	$40.00	$44,000.00	346,795
2/19/2021	Lawrence J Hineline	CFO	Sell	10,442	$39.23	$409,639.66	10,442
2/19/2021	Mark Neumann	EVP	Sell	5,184	$39.22	$203,316.48	50,523
2/19/2021	Sharon Mates	CEO	Sell	27,847	$39.23	$1,092,437.81	1,161,239
2/19/2021	Suresh K Durgam	Insider	Sell	2,734	$39.25	$107,309.50	25,838
1/11/2021	Lawrence J. Hineline	CFO	Sell	19,638	$32.02	$628,808.76
1/11/2021	Mark Neumann	EVP	Sell	9,684	$32.02	$310,081.68	49,068
1/11/2021	Sharon Mates	CEO	Sell	41,896	$32.01	$1,341,090.96	1,175,288
1/11/2021	Suresh K Durgam	Insider	Sell	4,367	$32.12	$140,268.04	21,851
1/4/2021	Lawrence J Hineline	CFO	Sell	15,810	$31.31	$495,011.10
1/4/2021	Michael Halstead	EVP	Sell	16,160	$31.30	$505,808.00
1/4/2021	Sharon Mates	CEO	Sell	48,341	$31.30	$1,513,073.30
11/17/2020	Michael Halstead	EVP	Sell	79,425	$27.62	$2,193,718.50	79,425
11/11/2020	Lawrence J Hineline	CFO	Sell	28,034	$25.41	$712,343.94	18,034
11/4/2020	Sharon Mates	CEO	Sell	50,000	$25.00	$1,250,000.00	1,163,392
10/16/2020	Mark Neumann	EVP	Sell	6,792	$26.80	$182,025.60	34,912
9/14/2020	Christopher D Alafi	Director	Buy	49,500	$29.60	$1,465,200.00	345,223
9/11/2020	Christopher D Alafi	Director	Buy	21,000	$28.08	$589,680.00
9/9/2020	Lawrence J Hineline	CFO	Sell	41,983	$31.14	$1,307,350.62	50,017
5/13/2020	Joel S Marcus	Director	Sell	7,297	$20.63	$150,537.11	14,374
5/11/2020	Joel S Marcus	Director	Sell	50,000	$19.95	$997,500.00	14,374
1/9/2020	Andrew Satlin	EVP	Sell	11,573	$26.16	$302,749.68	22,911
1/9/2020	Lawrence J Hineline	CFO	Sell	19,638	$26.16	$513,730.08	18,800
1/9/2020	Sharon Mates	CEO	Sell	41,895	$26.16	$1,095,973.20	1,204,707
1/6/2020	Michael Halstead	EVP	Sell	21,458	$30.34	$651,035.72	17,704
1/6/2020	Sharon Mates	CEO	Sell	45,598	$30.28	$1,380,707.44	1,182,366
1/2/2020	Michael Halstead	EVP	Sell	7,807	$32.43	$253,181.01	7,998
1/2/2020	Sharon Mates	CEO	Sell	17,478	$32.45	$567,161.10	1,156,185
10/16/2019	Mark Neumann	EVP	Sell	6,774	$8.25	$55,885.50	13,448
9/10/2019	Christopher D Alafi	Director	Buy	485,000	$10.26	$4,976,100.00	341,223
8/30/2019	Christopher D Alafi	Director	Buy	125,000	$8.52	$1,065,000.00	341,223
6/12/2019	Christopher D Alafi	Director	Buy	170,000	$11.73	$1,994,100.00	750,106
5/14/2019	Christopher D Alafi	Director	Buy	100,000	$12.56	$1,256,000.00	750,106
2/27/2019	Lawrence J Hineline	CFO	Sell	1,000	$15.00	$15,000.00	25,832
1/7/2019	Kimberly E Vanover	SVP	Sell	592	$12.29	$7,275.68	37,224
1/7/2019	Michael Halstead	EVP	Sell	3,108	$12.42	$38,601.36	24,757
1/7/2019	Sharon Mates	CEO	Sell	6,604	$12.43	$82,087.72	1,190,909
1/4/2019	Kimberly E Vanover	SVP	Sell	9,564	$11.47	$109,699.08	37,224
1/4/2019	Michael Halstead	EVP	Sell	21,458	$11.46	$245,908.68	24,757
1/4/2019	Sharon Mates	CEO	Sell	45,598	$11.45	$522,097.10	1,190,909
1/2/2019	Lawrence J Hineline	SVP	Sell	7,807	$11.09	$86,579.63	24,839
1/2/2019	Sharon Mates	CEO	Sell	17,478	$11.09	$193,831.02	1,156,185
12/6/2018	Robert E Davis	SVP	Sell	899	$13.53	$12,163.47	31,155
11/12/2018	Joel S Marcus	Director	Sell	32,000	$18.17	$581,440.00	21,671
11/9/2018	Joel S Marcus	Director	Sell	25,000	$18.24	$456,000.00	21,671
2/16/2018	Lawrence J Hineline	VP	Sell	49,700	$20.02	$994,994.00
1/22/2018	Michael Halstead	SVP	Sell	25,500	$18.03	$459,765.00	191
1/8/2018	Kimberly E Vanover	SVP	Sell	772	$17.46	$13,479.12	12,373
1/8/2018	Sharon Mates	Chairman	Sell	6,604	$17.48	$115,437.92	1,088,707
1/5/2018	Kimberly E Vanover	SVP	Sell	1,185	$17.37	$20,583.45	26,803
1/5/2018	Sharon Mates	Chairman	Sell	11,257	$17.08	$192,269.56	1,099,964
1/4/2018	Lawrence J Hineline	CFO	Sell	3,192	$15.67	$50,018.64	68,686
12/29/2017	Christopher D Alafi	Director	Buy	1,001	$14.48	$14,494.48
12/11/2017	Richard A Lerner	Director	Sell	7,000	$15.09	$105,630.00	8,621
12/5/2017	Robert E Davis	SVP	Sell	650	$15.00	$9,750.00	28,514
11/22/2017	Christopher D Alafi	Director	Buy	10,000	$15.55	$155,500.00	744,466
10/30/2017	Sharon Mates	CEO	Sell	18,750	$15.75	$295,312.50	1,107,457
10/2/2017	Alafi Capital Co Llc	Major Shareholder	Buy	258,065	$15.50	$4,000,007.50	3,953,270
1/5/2017	Lawrence J Hineline	VP	Sell	1,918	$16.58	$31,800.44	63,389
1/5/2017	Michael Halstead	SVP	Sell	1,601	$16.55	$26,496.55	21,506
1/5/2017	Sharon Mates	Chairman	Sell	4,081	$16.55	$67,540.55	1,088,707
12/15/2016	Kimberly E Vanover	SVP	Sell	9,375	$15.23	$142,781.25	5,000
12/7/2016	Alafi Capital Co Llc	Major Shareholder	Buy	65,000	$16.27	$1,057,550.00	3,674,379
11/14/2016	Christopher D Alafi	Director	Buy	34,000	$14.50	$493,000.00	730,529
2/29/2016	Christopher D Alafi	Director	Buy	100,000	$29.70	$2,970,000.00	728,828
12/15/2015	Lawrence J. Hineline	CFO	Sell	45,000	$51.45	$2,315,250.00	62,200
12/11/2015	Sharon Mates	CEO	Sell	51,500	$53.87	$2,774,305.00	1,086,185
12/8/2015	Joel S Marcus	Director	Sell	92,700	$54.47	$5,049,369.00	18,722
11/24/2015	Lawrence J Hineline	CFO	Sell	5,000	$55.00	$275,000.00	59,700
6/8/2015	Lawrence P Wennogle	VP	Sell	25,000	$26.84	$671,000.00
3/11/2015	Christopher D Alafi	Director	Buy	625,000	$24.00	$15,000,000.00
12/9/2014	Lawrence J Hineline	CFO	Sell	22,500	$16.71	$375,975.00
12/1/2014	Moshe Alafi	Major Shareholder	Buy	1,422	$14.75	$20,974.50
11/28/2014	Christopher D Alafi	Director	Buy	35,000	$14.75	$516,250.00
11/19/2014	Alafi Capital Co Llc	Major Shareholder	Buy	1,034	$14.25	$14,734.50
11/18/2014	Alafi Capital Co Llc	Major Shareholder	Buy	3,664	$14.26	$52,248.64
11/13/2014	Alafi Capital Co Llc	Major Shareholder	Buy	12,200	$15.34	$187,148.00
11/6/2014	Michael Halstead	SVP	Buy	20,000	$15.38	$307,600.00
10/15/2014	Lawrence P Wennogle	VP	Sell	3,604	$15.00	$54,060.00
10/13/2014	Lawrence P Wennogle	VP	Sell	1,600	$15.00	$24,000.00
10/8/2014	Lawrence P Wennogle	VP	Sell	4,745	$15.00	$71,175.00
10/6/2014	Lawrence P Wennogle	VP	Sell	16,499	$15.00	$247,485.00
9/15/2014	Lawrence P Wennogle	VP	Sell	5,000	$15.00	$75,000.00
9/8/2014	Lawrence J Hineline	CFO	Sell	300	$15.00	$4,500.00
5/22/2014	Lawrence P Wennogle	VP	Sell	6,000	$15.00	$90,000.00

(Data available from 1/1/2013 forward)

Intra-Cellular Therapies (NASDAQ:ITCI) Insider Trade Frequently Asked Questions

Who is on Intra-Cellular Therapies's Insider Roster?: The list of insiders at Intra-Cellular Therapies includes Andrew Satlin, Christopher D Alafi, Joel S Marcus, Lawrence J Hineline, Mark Neumann, Michael Halstead, Rory B Riggs, Sharon Mates, and Suresh K Durgam. Learn more on insiders at ITCI.
What percentage of Intra-Cellular Therapies stock is owned by insiders?: 13.20% of Intra-Cellular Therapies stock is owned by insiders. Learn more on ITCI's insider holdings.
Which Intra-Cellular Therapies insiders have been buying company stock?: The following insider purchased Intra-Cellular Therapies stock in the last 24 months: Christopher D Alafi ($2,054,880.00).

How much insider buying is happening at Intra-Cellular Therapies?: Insiders have purchased a total of 70,500 Intra-Cellular Therapies shares in the last 24 months for a total of $2,054,880.00 bought.
Which Intra-Cellular Therapies insiders have been selling company stock?: The following insiders have sold Intra-Cellular Therapies stock in the last 24 months: Christopher D Alafi ($1,414,855.07), Joel S Marcus ($1,595,676.03), Lawrence J Hineline ($13,019,007.54), Mark Neumann ($8,686,036.81), Michael Halstead ($11,111,130.78), Rory B Riggs ($5,087,501.84), Sharon Mates ($11,565,102.50), and Suresh K Durgam ($1,683,894.84).
How much insider selling is happening at Intra-Cellular Therapies?: Insiders have sold a total of 1,262,411 Intra-Cellular Therapies shares in the last 24 months for a total of $54,836,014.17 sold.

This page was last updated on 5/22/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Intra-Cellular Therapies Insider Trades

Insider Buying and Selling by Quarter

Intra-Cellular Therapies (NASDAQ:ITCI) Insider Trading History

Intra-Cellular Therapies (NASDAQ:ITCI) Insider Trade Frequently Asked Questions

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Intra-Cellular Therapies Insider Trades

Intra-Cellular Therapies (NASDAQ:ITCI) Insider Buying and Selling Activity

Insider Buying and Selling by Quarter

Intra-Cellular Therapies (NASDAQ:ITCI) Insider Trading History

Intra-Cellular Therapies (NASDAQ:ITCI) Insider Trade Frequently Asked Questions

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources